L365-3533 Screening compound: 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}urea

L365-3533 Screening compound: 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}urea
L365-3533 Screening compound: 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}urea alternative view

Chemical Structure Depiction of ChemDiv screening compound L365-3533
3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L365-3533

Molecular Formula

C30H26N4O3 (C30 H26 N4 O3)

Compound Name

3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}urea

IUPAC name

3-(23-dihydro-14-benzodioxin-6-yl)-1-{4-[2-(1-phenyl-1H-13-benzodiazol-2-yl)ethyl]phenyl}urea

SMILES

O=C(Nc1ccc(CCc2nc(cccc3)c3n2-c2ccccc2)cc1)Nc(cc1)cc2c1OCCO2

InChI

InChI=1S/C30H26N4O3/c35-30(32-23-15-16-27-28(20-23)37-19-18-36-27)31-22-13-10-21(11-14-22)12-17-29-33-25-8-4-5-9-26(25)34(29)24-6-2-1-3-7-24/h1-11,13-16,20H,12,17-19H2,(H2,31,32,35)

InChI Key

GCBNWSLDFNFVFZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15125167

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.714

Distribution Coefficient, logD

5.662

Water Solubility, LogSw

-5.82

Polar Surface Area

59.741

Acid Dissociation Constant (pKa)

12.33

Base Dissociation Constant (pKb)

6.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.30

L365-3533 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

PI3K-Targeted Library (17255 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L365-3533 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L365-3533?
Check Price and Availability of L365-3533, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L365-3533 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L365-3533
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L365-3533
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L365-3533 available by request